TGM2 and Dravet syndrome: Our results showed that inhibition of TG2 by NC9 in ATRA + ATO combined treatment significantly reduces not just reactive oxygen species (ROS) but also proinflammatory cytokines and chemokine production that significantly increases the severity of DS.